Cargando…

Inflammation and cardiovascular status impact midazolam pharmacokinetics in critically ill children: An observational, prospective, controlled study

Altered physiology caused by critical illness may change midazolam pharmacokinetics and thereby result in adverse reactions and outcomes in this vulnerable patient population. This study set out to determine which critical illness‐related factors impact midazolam pharmacokinetics in children using p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Neupane, Bikalpa, Pandya, Hitesh, Pandya, Tej, Austin, Rupert, Spooner, Neil, Rudge, James, Mulla, Hussain
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422629/ https://www.ncbi.nlm.nih.gov/pubmed/36036654 http://dx.doi.org/10.1002/prp2.1004

Ejemplares similares

Effect of critical illness on the pharmacokinetics and dose-response relationship of midazolam
por: Ovakim, D, et al.
Publicado: (2012)

Pharmacokinetics Alterations of Midazolam Infusion versus Bolus Administration in Mechanically Ventilated Critically Ill Patients
por: Beigmohammadi, Mohammad Taghi, et al.
Publicado: (2013)

The Oral Bioavailability and Metabolism of Midazolam in Stable Critically Ill Children: A Pharmacokinetic Microtracing Study
por: van Groen, Bianca D., et al.
Publicado: (2020)

Pharmacokinetics of Haloperidol in Critically Ill Patients: Is There an Association with Inflammation?
por: Li, Letao, et al.
Publicado: (2022)

Hyperinflammation Reduces Midazolam Metabolism in Critically Ill Adults with COVID-19
por: Smeets, Tim J. L., et al.
Publicado: (2022)

Effect of midazolam on delirium in critically ill patients: a propensity score analysis
por: Shi, He-Jie, et al.
Publicado: (2022)

Pharmacokinetic interaction of ketoconazole, clarithromycin, and midazolam with riociguat
por: Becker, Corina, et al.
Publicado: (2013)

Pharmacokinetic–Pharmacodynamic Modeling of Midazolam in Pediatric Surgery
por: Flores-Pérez, Carmen, et al.
Publicado: (2023)

Predicting CYP3A‐mediated midazolam metabolism in critically ill neonates, infants, children and adults with inflammation and organ failure
por: Brussee, Janneke M., et al.
Publicado: (2017)

Embedding sports and exercise medicine into the medical curriculum; a call for inclusion
por: Pandya, Tej, et al.
Publicado: (2018)

An evaluation of ciprofloxacin pharmacokinetics in critically ill patients undergoing continuous veno-venous haemodiafiltration
por: Spooner, Almath M, et al.
Publicado: (2011)

Comparative Study of Intranasal Dexmedetomidine v/s Midazolam for Sedation of Pediatric Patients During Transthoracic Echocardiography
por: Panda, Suvendu, et al.
Publicado: (2021)

Outcomes in Critically Ill Patients Sedated with Intravenous Lormetazepam or Midazolam: A Retrospective Cohort Study
por: Weiss, Björn, et al.
Publicado: (2021)

Sex and Age Influence on Association of CYP450 Polymorphism with Midazolam Levels in Critically Ill Children
por: Flores-Pérez, Carmen, et al.
Publicado: (2022)

Catecholamine pharmacokinetics and pharmacodynamics in critical illness
por: Johnston, AJ, et al.
Publicado: (2003)

Pharmacokinetics of Micafungin in Critically Ill Patients
por: Gastine, Silke, et al.
Publicado: (2019)

Pharmacokinetics of Esomeprazole in Critically Ill Patients
por: Xu, Yanyan, et al.
Publicado: (2022)

Pharmacokinetic Alterations Associated with Critical Illness
por: Morales Castro, Diana, et al.
Publicado: (2023)

Pharmacokinetics and clinical efficacy of midazolam in children with severe malaria and convulsions
por: Muchohi, Simon N, et al.
Publicado: (2008)

Effects of berberine on pharmacokinetics of midazolam and rhodamine 123 in rats in vivo
por: Xin, Hua-Wen, et al.
Publicado: (2016)

Composite midazolam and 1′-OH midazolam population pharmacokinetic model for constitutive, inhibited and induced CYP3A activity
por: Wiebe, Sabrina T., et al.
Publicado: (2020)

Critical care in obstetrics
por: Pandya, Sunil T, et al.
Publicado: (2018)

Inadequate Sedation During Therapeutic Paralysis: Use of Bispectral Index in Critically Ill Patients
por: Tasaka, Chelsea L., et al.
Publicado: (2016)

Dose‐linearity of the pharmacokinetics of an intravenous [(14)C]midazolam microdose in children
por: van Groen, Bianca D., et al.
Publicado: (2019)

Population Pharmacokinetics of Dexmedetomidine in Critically Ill Patients
por: Välitalo, Pyry Antti, et al.
Publicado: (2013)

Pharmacokinetics of Intravenous Posaconazole in Critically Ill Patients
por: Sime, Fekade B., et al.
Publicado: (2018)

Population pharmacokinetics of tigecycline in critically ill patients
por: Luo, Xiangru, et al.
Publicado: (2023)

Population Pharmacokinetic Model Characterizing 24-Hour Variation in the Pharmacokinetics of Oral and Intravenous Midazolam in Healthy Volunteers
por: van Rongen, A, et al.
Publicado: (2015)

Conservative management of fifth metacarpal head fracture in a professional cricketer: A case study and literature review
por: Pandya, Tej, et al.
Publicado: (2020)

Effects of Repeated Oral Administration of Esaxerenone on the Pharmacokinetics of Midazolam in Healthy Japanese Males
por: Toyama, Kaoru, et al.
Publicado: (2021)

Tolerability and pharmacokinetics of intravenous allopregnanolone with and without midazolam pretreatment in two healthy dogs
por: Bruun, Donald A., et al.
Publicado: (2023)

Pharmacokinetics of orally administered melatonin in critically ill patients
por: Moroni, B, et al.
Publicado: (2010)

Amikacin Population Pharmacokinetics in Critically Ill Kuwaiti Patients
por: Matar, Kamal M., et al.
Publicado: (2013)

Efficacy and pharmacokinetics of intravenous paracetamol in the critically ill patient
por: Samson, AD, et al.
Publicado: (2009)

Pharmacokinetics of Favipiravir in Critically Ill Patients With COVID‐19
por: Irie, Kei, et al.
Publicado: (2020)

Pharmacokinetics of enoxaparin in COVID-19 critically ill patients
por: Zufferey, Paul Jacques, et al.
Publicado: (2021)

Pharmacokinetics of meropenem in critically ill patients in Saudi Arabia
por: Alsultan, Abdullah, et al.
Publicado: (2021)

Total and Unbound Pharmacokinetics of Cefiderocol in Critically Ill Patients
por: Zahr, Noël, et al.
Publicado: (2022)

Meropenem Pharmacokinetics and Target Attainment in Critically Ill Patients
por: Gan, Yuhong, et al.
Publicado: (2023)

Pharmacokinetics of baricitinib in critically ill COVID-19 patients
por: Massart, Nicolas, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_odhraj9scp4tu7ia1vgmm7pstk